Search Results for "conflict of interest"
Study looks at possible publication bias/conflict of interest in medical journals
A study published in the BMJ analyzed “the extent to which funding and study design are associated with high reprint orders.” The authors explain: Reprints of published articles are a potential valuable means of disseminating information. Many individuals and organisations may request reprints, including the authors of the articles themselves, other members of the scientific […]11/7/2011
AP’s scanner story: blueprint for including conflict of interest in daily stories
The following is a guest blog post by William Heisel, one of our story reviewers on HealthNewsReview.org. ———————————————————————————————————–When writers mention conflict of interest in a story it typically is in one context: researchers taking money from Big Pharma. But conflicts abound in medical research, so much so that documenting all the conflicts can seem daunting, […]10/12/2011
Health care conflict of interest roundup – 3 newsworthy items
Item #1: How prevalent are financial conflicts of interest among people writing clinical practice guidelines in Canada and the US? An analysis published in the BMJ of 14 such guidelines reports: Among the 288 panel members, 138 (48%) reported conflicts of interest at the time of the publication of the guideline and 150 (52%) either […]8/3/2011
Concerns over FDA loosening conflict of interest rules
The FDA is apparently considering loosening the conflict-of-interest rules that apply to members of FDA advisory committee members. These rules have set limits on the financial arrangements that members can have with companies in the health care industry. The Project on Government Oversight wrote about the issue last week. If the perceived problem is that […]5/23/2011
Chicago Tribune reports on clinical trial ethics/conflict of interest question
The Chicago Tribune reports, “Patients at heart of medical device issue: Recipients of life-saving products may not know of potential conflicts of interest when doctors put their own inventions to use.” The Tribune reports that the case they report on: “… highlights the tangled web of interests patients face when they require medical devices …showing […]7/13/2010
Conflicting policies on conflict of interest at Michigan
Universities are obviously struggling with the whole conflict of interest concept. Duff Wilson of the New York Times, who reported recently that the University of Michigan medical school was abandoning industry support for continuing medical education, now reports that the University’s president “sits on the board of directors for the pharmaceutical giant Johnson & Johnson. […]3/19/2010
Avandia example: Underscoring the need for conflict of interest disclosure
As Reuters reports, “virtually all of the experts who wrote favorably about GlaxoSmithKline Plc’s troubled diabetes drug Avandia (rosiglitazone) had financial ties to drug makers, a finding that shows the need for reform of such relationships, U.S. researchers said on Thursday.” The study appears in the BMJ. Mayo’s Dr. Victor Montori told Reuters: “It was […]3/3/2010
Fox News contributor has conflict of interest on prostate CA screening discussion
Here’s another problem with the practice of TV networks using physician “contributors” to comment on health care news. They may have a clear conflict of interest that is not addressed. When the American Cancer Society released its updated guidelines on prostate cancer screening today, Fox News reported: “Dr. David Samadi, a Fox News contributor and […]11/4/2009
Medical conflict of interest issues in newspapers large and small today
I’ve told my students that covering health care conflicts of interest could be a fulltime beat – and you still wouldn’t keep up. The NY Times today reports: In the first half of this year, the drug giant Eli Lilly paid 3,971 doctors and other medical professionals an average of about $11,230 each. The payments […]8/10/2009
Low T, CME, and conflict of interest
In another in a continuing series of stories about doctors, drug companies and conflicts of interest, John Fauber of the Milwaukee Journal-Sentinel writes about the disease-mongering promotion of low testosterone or “Low T.” Excerpts: “A rash of television commercials in recent months have told millions of middle-age men that their diminished sex life and somber […]2/18/2009
Health Care Conflict of Interest Could be a Full-Time Beat
A collection of recent stories by mid-sized Midwestern newspapers are worthy of special attention. They all reported on issues of conflict of interest in health care and medical research. A series of reports by the Milwaukee Journal Sentinel asked tough questions about financial ties between drug companies and medical school physician faculty members. * "Doctors […]1/26/2009
Milwaukee paper keeps hammering on conflict of interest
The Milwaukee Journal Sentinel has done it again. This tough “medium market” (if I can call it that) newspaper faces tough economic times by scrapping to do more tough journalism. Just two weeks ago we blogged about one of their stellar health journalism efforts. Yesterday they published a 1,700-word story (that’s rare these days) raising […]12/1/2008
Conflict of interest on NPR's "On the Media"
NPR’s “On the Media” program this weekend looked at drug industry influence on media messages, including an interview with Senator Charles Grassley about his investigations of the industry. The program also featured an interview with me about our HealthNewsReview.org project and about other issues involving health care news sources’ conflicts of interest.6/18/2008
Tracking conflict of interest news coverage
From time to time, I’ve highlighted how the Integrity in Science Watch project of the Center for Science in the Public Interest tracks news coverage (or lack thereof) of conflicts of interest in medicine and science. This week’s offering: Cheer to Andrew Pollack of the New York Times for disclosing that Eric L. Matteson, […]
Conflict of interest with Big Tobacco?
Tonight, medical research, and a study of a possible way to find early stage lung cancer that has gotten a lot of attention. It’s back in the news today because we learned who was paying for part of that research, and now there are questions that need answers.